S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

CNTX Context Therapeutics Inc

1.15

0.17 (17.35%)

Dec 24 2024 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Context Therapeutics (NASDAQ:CNTX)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Context Therapeutics Charts.

Context Therapeutics (NASDAQ:CNTX)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Context Therapeutics Charts.

Context Therapeutics Inc News

Form 8-K - Current report
Monday 23 December 2024 (2 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 2 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Monday 2 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Wednesday 6 November 2024 (2 months ago) • Edgar (US Regulatory)

Context Therapeutics Reports Third Quarter 2024 Operating and Financial Results
Wednesday 6 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 6 November 2024 (2 months ago) • Edgar (US Regulatory)

Context Therapeutics to Participate in Upcoming Investor Conferences in November
Wednesday 23 October 2024 (2 months ago) • GlobeNewswire Inc.

Context Therapeutics Announces Poster Presentation at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
Wednesday 16 October 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 23 September 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 17 September 2024 (3 months ago) • Edgar (US Regulatory)

More Context Therapeutics Inc News Articles

Digital Brand Media and ... (PK)

Intergrated Cannabis Sol... (PK)

Anavex Life Sciences

Fannie Mae (QB)

Northwest Biotherapeutics (QB)

Code Green Apparel (PK)

Lightwave Logic

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions